CURRICULUM VITAE - Stanford University School of Medicine

35. Holodniy M, Katzenstein DA, Winters M, Montoya J, Shafer R, Kozal M, Ragni M, and
Merigan TC. Measurement of HIV Virus Load and Genotypic Resistance by Gene
Amplification in Asymptomatic Subjects Treated with Combination Therapy. Journal of
Acquired Immune Deficiency Syndromes, 6: 366-369, 1993.
36. Hamed KA, Winters MA, Holodniy M, Katzenstein DA, and Merigan TC. Detection of
Human Immunodeficiency Virus Type 1 in Semen: Effects of Disease Stage and
Nucleoside Therapy. Journal of Infectious Diseases, 167: 798-802, 1993.
37. Montoya J, Wood R, Katzenstein DA, Holodniy M, and Merigan, TC. Peripheral Blood
Mononuclear Cell DNA Quantification for Diagnosis of Human Immunodeficiency Virus
Infection in Adults. Journal of Clinical Microbiology, 31 :2692-6, 1993.
38. Winters MA, Tan LB, Katzenstein DA, and Merigan TC. Biological variation and quality
control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse
transcriptase polymerase chain reaction. Journal of Clinical Microbiology, 31: 2960-6,
1993.
39. Katzenstein DA, Winters M, Israelski D, Bubp J, Winger E, and Merigan TC. Quantitation
of human immunodeficiency virus by culture and polymerase chain reaction in response
to didanosine after long term therapy with Zidovudine. Journal of Infectious Diseases,
169: 416-9, 1994.
40. Shafer RW, Kozal MJ, Winters MA, Iversen AKN, Katzenstein DA, Ragni MV, Meyer WA
III, Gupta P, Rasheed S, Coombs R, Katzman M, Fiscus S, and Merigan TC.
Combination therapy with zidovudine and didanosine selects for drug-resistant human
immunodeficiency virus type 1 strains with unique pol gene mutations. Journal of
Infectious Diseases, 169: 722-9, 1994.
41. Ramachandran RV, Katzenstein DA, Wood R, Batts DH, and Merigan TC. Failure of
short term CD4-PE40 infusions to reduce viral load in human immunodeficiency virus
infected individuals. Journal of Infectious Diseases, 170: 1009-13, 1994.
42. Kozal MJ, Kroodsma K, Winters MA, Shafer RW, Efron B, Katzenstein DA, and Merigan
TC. Didanosine resistance mutation in HIV-infected patients switched from zidovudine
to didanosine monotherapy. Annals of Internal Medicine, 121: 263-268, 1994.
43. Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Aguniga E, Halpern J, and Merigan
TC. HIV-1 syncytium inducing phenotype, virus burden, codon 215 reverse transcriptase
mutation and CD4 cell decline in Zidovudine treated patients. Journal of Acquired
Immune Deficiency Syndromes, 7: 832-38, 1994.
44. Ramachandran RV, Katzenstein DA, and Merigan TC. Long-term effects of interleukin-2
on CD4 cell counts in human immunodeficiency virus-infected patients. (letter) Journal of
Infectious Diseases, 170: 1044-6, 1994.
45. Mbizvo MT, Ray S, Bassett M, McFarland W, Machekano R, and Katzenstein DA.
Condom use and the risk of HIV infection: who is being protected? Central African
7